<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"
xmlns:rawvoice="http://www.rawvoice.com/rawvoiceRssModule/"
	>
<channel>
	<title>Comments on: Links and Reading for September 18th</title>
	<atom:link href="http://www.thedisciplinedinvestor.com/blog/2009/09/18/links-for-september-18th/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.thedisciplinedinvestor.com/blog/2009/09/18/links-for-september-18th/</link>
	<description>Investment Disciplines and Timely Advice.</description>
	<lastBuildDate>Fri, 10 Feb 2012 21:15:03 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
	<item>
		<title>By: Andrew Horowitz</title>
		<link>http://www.thedisciplinedinvestor.com/blog/2009/09/18/links-for-september-18th/comment-page-1/#comment-9211</link>
		<dc:creator>Andrew Horowitz</dc:creator>
		<pubDate>Sat, 19 Sep 2009 00:35:03 +0000</pubDate>
		<guid isPermaLink="false">http://www.thedisciplinedinvestor.com/blog/?p=4830#comment-9211</guid>
		<description>Exactly. That is why I wrote PR </description>
		<content:encoded><![CDATA[<p>Exactly. That is why I wrote PR</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Alex</title>
		<link>http://www.thedisciplinedinvestor.com/blog/2009/09/18/links-for-september-18th/comment-page-1/#comment-9207</link>
		<dc:creator>Alex</dc:creator>
		<pubDate>Fri, 18 Sep 2009 21:54:14 +0000</pubDate>
		<guid isPermaLink="false">http://www.thedisciplinedinvestor.com/blog/?p=4830#comment-9207</guid>
		<description>Andrew, the &quot;ghostwriting&quot; thing is about drug companies writing research papers for scientists, and the scientists taking credit for it. Then the drug companies will use the findings (valid or otherwise) in the research paper to validate their claims to the FDA. </description>
		<content:encoded><![CDATA[<p>Andrew, the &quot;ghostwriting&quot; thing is about drug companies writing research papers for scientists, and the scientists taking credit for it. Then the drug companies will use the findings (valid or otherwise) in the research paper to validate their claims to the FDA.</p>
]]></content:encoded>
	</item>
</channel>
</rss>

